{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:48:34Z","timestamp":1786996114941,"version":"build-2736575974"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004898","name":"EORTC Charitable Trust","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004898","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.radonc.2012.08.006","type":"journal-article","created":{"date-parts":[[2012,9,16]],"date-time":"2012-09-16T04:30:51Z","timestamp":1347769851000},"page":"238-240","source":"Crossref","is-referenced-by-count":14,"title":["EORTC 24051: Unexpected side effects in a phase I study of TPF induction chemotherapy followed by chemoradiation with lapatinib, a dual EGFR\/ErbB2 inhibitor, in patients with locally advanced resectable larynx and hypopharynx squamous cell carcinoma"],"prefix":"10.1016","volume":"105","author":[{"given":"Yassine","family":"Lalami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pol M.","family":"Specenier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Awada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Lacombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Liberatoscioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Fortpied","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iman","family":"El-Hariry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Bogaerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Andry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"Langendijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan B.","family":"Vermorken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2012.08.006_b0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semradonc.2008.09.002","article-title":"Current state-of-the-art for concurrent chemoradiation","volume":"19","author":"Bernier","year":"2009","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.radonc.2012.08.006_b0010","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa031317","article-title":"Phase III trial to preserve the larynx: induction chemotherapy and radiotherapy versus concomitant chemoradiotherapy versus radiotherapy alone: intergroup trial R91-11","volume":"349","author":"Forastiere","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2012.08.006_b0015","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1200\/JCO.1998.16.4.1318","article-title":"Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study","volume":"16","author":"Wendt","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2012.08.006_b0020","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1200\/JCO.2007.14.8841","article-title":"Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis","volume":"26","author":"Machtay","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2012.08.006_b0025","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1056\/NEJM199301213280306","article-title":"Head and neck cancer","volume":"328","author":"Vokes","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2012.08.006_b0030","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients","volume":"92","author":"Pignon","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2012.08.006_b0035","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJMoa070956","article-title":"Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer","volume":"357","author":"Posner","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2012.08.006_b0040","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1093\/annonc\/mdn752","article-title":"Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX324: survival, surgery, and organ preservation","volume":"20","author":"Posner","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2012.08.006_b0045","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa071028","article-title":"Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer","volume":"357","author":"Vermorken","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2012.08.006_b0050","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1093\/jnci\/djp007","article-title":"Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation","volume":"101","author":"Pointreau","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2012.08.006_b0055","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/S0167-8140(11)70005-6","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site","volume":"98","author":"Blanchard","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2012.08.006_b0060","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/hed.2880130209","article-title":"Characterization, quantification, and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomas","volume":"13","author":"Santini","year":"1991","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2012.08.006_b0065","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1002\/(SICI)1097-0142(19960915)78:6<1284::AID-CNCR17>3.0.CO;2-X","article-title":"Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck","volume":"78","author":"Grandis","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2012.08.006_b0070","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/jnci\/90.11.824","article-title":"Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival","volume":"90","author":"Grandis","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2012.08.006_b0075","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1200\/JCO.1993.11.10.1873","article-title":"Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer","volume":"11","author":"Dassonville","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2012.08.006_b0080","first-page":"85","article-title":"The effects of the novel, reversible epidermal growth factor receptor\/ErbB-2 tyrosine kinase inhibitor, GW572016, on the growth of human normal and tumor-derived cell lines in vitro and in vivo","volume":"1","author":"Rusnak","year":"2001","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.radonc.2012.08.006_b0085","first-page":"23","article-title":"Clinical activity of GW572016 in EGF10003 in patients with solid tumors","author":"Versola","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2012.08.006_b0090","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/bjc.2011.237","article-title":"Effects of lapatinib monotherapy: results of a randomised phase II study in therapy-na\u00efve patients with locally advanced squamous cell carcinoma of the head and neck","volume":"105","author":"Del Campo","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.radonc.2012.08.006_b0095","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1200\/JCO.2007.14.9633","article-title":"Phase I pharmacokinetics study of lapatinib and docetaxel in patients with advanced cancer","volume":"26","author":"LoRusso","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2012.08.006_b0100","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1200\/JCO.2008.17.5349","article-title":"Phase I study of lapatinib in combination with chemoradiation in patients with locally advanced squamous cell carcinoma of the head and neck","volume":"27","author":"Harrington","year":"2009","journal-title":"J Clin Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781401200357X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781401200357X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T14:23:14Z","timestamp":1542723794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016781401200357X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S016781401200357X"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2012.08.006","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}